Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers

Reproductive Toxicology

Volumn 31, Issue 4, 2011, Pages 540-545

  Diav Citrin, Orna ^a   Shechtman, Svetlana ^a   Halberstadt, Yehudit ^b   Finkel Pekarsky, Victoriya ^a,b   Wajnberg, Rebecka ^a   Arnon, Judy ^a   Di Gianantonio, Elena ^c   Clementi, Maurizio ^c   Ornoy, Asher ^a,b  

^a MINISTRY OF HEALTH   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c Servizio di Informazione Teratologica   (Italy)

Author keywords

Angiotensin converting enzyme inhibitors; Angiotensin receptor blockers; Congenital anomalies; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HALOPERIDOL; HYDROCHLOROTHIAZIDE; LABETALOL; LAMOTRIGINE; LISINOPRIL; METHYLDOPA; METOPROLOL; NIFEDIPINE; PROPRANOLOL; PROPYLTHIOURACIL; QUINAPRIL; RAMIPRIL; SIMVASTATIN; THIAZIDE DIURETIC AGENT; THYROXINE; VERAPAMIL;

ANENCEPHALUS; ANUS DISEASE; ARM MALFORMATION; ARTICLE; BIRTH WEIGHT; BLADDER MALFORMATION; BONE MALFORMATION; CONGENITAL MALFORMATION; CONTROLLED STUDY; CRYPTORCHISM; DEVELOPMENTAL DISORDER; DISEASE CONTROL; DRUG EFFECT; DRUG INDICATION; DRUG SAFETY; ECTOPIC PREGNANCY; EPILEPSY; EXTERNAL EAR MALFORMATION; FEMUR MALFORMATION; FIRST TRIMESTER PREGNANCY; FOOT MALFORMATION; GESTATIONAL AGE; HAND MALFORMATION; HEART VENTRICLE SEPTUM DEFECT; HIP DYSPLASIA; HORSESHOE KIDNEY; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPERTROPHIC PYLORUS STENOSIS; HYPOSPADIAS; HYPOTHYROIDISM; INGUINAL HERNIA; INTESTINE STENOSIS; KARYOTYPE 47,XYY; KIDNEY MALFORMATION; KIDNEY POLYCYSTIC DISEASE; LIPOMA; MENTAL DEFICIENCY; MICROCEPHALY; MICROTIA; MULTIPLE PREGNANCY; PATENT DUCTUS ARTERIOSUS; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRUNE BELLY SYNDROME; SCHIZOPHRENIA; SEX CHROMOSOME MOSAICISM; SHOULDER DISEASE; SINGLE UMBILICAL ARTERY; SPONTANEOUS ABORTION; STRABISMUS; SYNDACTYLY; TERATOGEN TESTING; TESTIS DISEASE; TRACHEOMALACIA; TREATMENT DURATION; TRISOMY 21; URINARY TRACT OBSTRUCTION;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANALYSIS OF VARIANCE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BIRTH WEIGHT; CHI-SQUARE DISTRIBUTION; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; ISRAEL; ITALY; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PREMATURE BIRTH; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 79956349425     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2011.02.008     Document Type: Article

References (34)

1. Lonn E.M., Yusuf S., Jha P., Montague T.J., Teo K.K., Benedict C.R., et al. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 1994, 90:2056-2069.
2. Lewis E.J., Hunsicker L.G., Bain R.P., Rohde R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993, 329:1456-1462.
3. Stevenson K.M., Gibson K.J., Lumbers E.R. Comparison of the transplacental transfer of enalapril, captopril and losartan in sheep. Br J Pharmacol 1995, 114:1495-1501.
4. Reisenberger K., Egarter C., Sternberger B., Eckenberger P., Eberle E., Weissenbacher E.R. Placental passage of angiotensin-converting enzyme inhibitors. Am J Obstet Gynecol 1996, 174:1450-1455.
5. Broughton Pipkin F., Turner S.R., Symonds E.M. Possible risk with captopril in pregnancy: some animal data. Lancet 1980, 1:1256.
6. Harewood W.J., Phippard A.F., Duggin G.G., Horvath J.S., Tiller D.J. Fetotoxicity of angiotensin-converting enzyme inhibition in primate pregnancy: a prospective, placebo-controlled study in baboons (Papio hamadryas). Am J Obstet Gynecol 1994, 171:633-642.
7. Guignard J.P., Burgener F., Calame A. Persistent anuria in a neonate: a side effect of captopril?. Int J Pediatr Nephrol 1981, 2:133. [abstract].
8. Rosa F.W., Bosco L.A., Graham C.F., Milstien J.B., Dreis M., Creamer J. Neonatal anuria with maternal angiotensin-converting enzyme inhibition. Obstet Gynecol 1989, 74:371-374.
9. Barr M., Cohen MM. ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection. Teratology 1991, 44:485-495.
10. Barr M. Teratogen update: angiotensin-converting enzyme inhibitors. Teratology 1994, 50:399-409.
11. Schaefer C. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity. Birth Defects Res A: Clin Mol Teratol 2003, 67:591-594.
12. Alwan S., Polifka J.E., Friedman J.M. Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res A: Clin Mol Teratol 2005, 73:123-130.
13. Creft-Jais C., Plouin P.F., Tchobroutsky C., Boutroy M.J. Angiotensin-converting enzyme inhibitors during pregnancy: survey of 22 patients given captopril and nine given enalapril. Br J Obstet Gynaecol 1988, 95:420-422.
14. Piper J.M., Ray W.A., Rosa F.W. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors. Obstet Gynecol 1992, 80:429-432.
15. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk 2005, Rosa F, personal communication, 1993, as cited in:, Lippincott Williams & Wilkins, Philadelphia, PA, USA, p. 212, 549, 927. 7th ed. G.G. Briggs, R.K. Freeman, S.J. Yaffe (Eds.).
16. Feldkamp M., Jones K.L., Ornoy A., Pastuszak A., Rosenwasser S., Schick B., et al. Postmarketing surveillance for angiotensin converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995. JAMA 1997, 277:1193-1194.
17. Lip G.Y., Churchill D., Beevers M., Auckett M., Beevers D.G. Angiotensin-converting-enzyme inhibitors in early pregnancy. Lancet 1997, 350:1446-1447.
18. Bar J., Hod M., Merlob P. Angiotensin converting enzyme inhibitors use in the first trimester of pregnancy. Int J Risk Safety Med 1997, 10:23-26.
19. Steffensen F.H., Nielsen G.L., Sørensen H.T., Olesen C., Olsen J. Pregnancy outcome with ACE-inhibitor use in early pregnancy. Lancet 1998, 351:596.
20. Yip S.K., Leung T.N., Fung H.Y. Exposure to angiotensin-converting enzyme inhibitors during first trimester: is it safe to fetus?. Acta Obstet Gynecol Scand 1998, 77:570-571.
21. Burrows R.F., Burrows E.A. Assessing the teratogenic potential of angiotensin-converting enzyme inhibitors in pregnancy. Aust N Z J Obstet Gynaecol 1998, 38:306-311.
22. Cooper W.O., Hernandez-Diaz S., Arbogast P.G., Dudley J.A., Dyer S., Gideon P.S., et al. Major congenital malformations after first-trimester exposure to ACE-inhibitors. N Engl J Med 2006, 354:2443-2451.
23. Scially A.R., Lione A. ACE inhibitors and major congenital malformations. N Engl J Med 2006, 355:1280.
24. Cooper W.O., Ray W.A. ACE inhibitors and major congenital malformations. N Engl J Med 2006, 355:1281.
25. Ray J.G., Vermeulen M.J., Koren G. Taking ACE inhibitors during early pregnancy: is it safe?. Can Fam Physician 2007, 53:1439-1440.
26. Malm H., Artama M., Gissler M., Klaukka T., Merilainen J., Nylander O., et al. First trimester use of ACE-inhibitors and risk of major malformations. Reprod Toxicol 2008, 26:67. [abstract].
27. Lennestål R., Otterblad Olausson P., Källén B. Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol 2009, 65:615-625.
28. Clementi M., Di Gianantonio E., Ornoy A. Teratology information services in Europe and their contribution to the prevention of congenital anomalies. Community Genet 2002, 5:8-12.
29. Schaefer C., Hannemann D., Meister R. Post-marketing surveillance system for drugs in pregnancy - 15 years experience of ENTIS. Reprod Toxicol 2005, 20:331-343.
30. Holmes L.B. Need for inclusion and exclusion criteria for the structural abnormalities recorded in children born from exposed pregnancies. Teratology 1999, 59:1-2. [editorial].
31. Rey E., Couturier A. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 1994, 171:410-416.
32. Gilbert W.M., Young A.L., Danielsen B. Pregnancy outcomes in women with chronic hypertension: a population-based study. J Reprod Med 2007, 52:1046-1051.
33. Sibai B.M., Caritis S.N., Hauth J.C., MacPherson C., VanDorsten J.P., Klebanoff M., et al. Preterm delivery in women with pregestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2000, 183:1520-1524.
34. Chatzi L., Plana E., Daraki V., Karakosta P., Alegkakis D., Tsatsanis C., et al. Metabolic syndrome in early pregnancy and risk of preterm birth. Am J Epidemiol 2009, 170:829-836.